BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15044084)

  • 1. Cisplatin resistance is associated with deregulation in protein kinase C-delta.
    Huang J; Mohanty S; Basu A
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1002-8. PubMed ID: 15044084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.
    Mohanty S; Huang J; Basu A
    Clin Cancer Res; 2005 Sep; 11(18):6730-7. PubMed ID: 16166454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta.
    Basu A; Tu H
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1068-73. PubMed ID: 16039614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of proteolytic activation of PKCdelta in cisplatin-induced apoptosis in human small cell lung cancer H69 cells.
    Persaud SD; Hoang V; Huang J; Basu A
    Int J Oncol; 2005 Jul; 27(1):149-54. PubMed ID: 15942654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p53 stabilization by DNA damage and protein kinase C.
    Johnson CL; Lu D; Huang J; Basu A
    Mol Cancer Ther; 2002 Aug; 1(10):861-7. PubMed ID: 12492119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Basu A; Weixel K; Saijo N
    Cell Growth Differ; 1996 Nov; 7(11):1507-12. PubMed ID: 8930400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of extrinsic and intrinsic cell death pathways by protein kinase C.
    Basu A; Miura A
    Int J Mol Med; 2002 Nov; 10(5):541-5. PubMed ID: 12373288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of protein kinase Cdelta enhances cisplatin-induced cytotoxicity correlated with p53 in gastric cancer cell line.
    Iioka Y; Mishima K; Azuma N; Tsuchida A; Takagi Y; Aoki T; Saito I
    Pathobiology; 2005; 72(3):152-9. PubMed ID: 15860933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular sensitization to cis-diamminedichloroplatinum(II) by novel analogues of the protein kinase C activator lyngbyatoxin A.
    Basu A; Kozikowski AP; Sato K; Lazo JS
    Cancer Res; 1991 May; 51(10):2511-4. PubMed ID: 2021930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
    Yang BF; Xiao C; Li H; Yang SJ
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC; de Vries EG; Vellenga E; de Jong S
    Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells.
    Mandil R; Ashkenazi E; Blass M; Kronfeld I; Kazimirsky G; Rosenthal G; Umansky F; Lorenzo PS; Blumberg PM; Brodie C
    Cancer Res; 2001 Jun; 61(11):4612-9. PubMed ID: 11389098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of protein kinase C-delta in DNA damage-induced apoptosis.
    Basu A; Woolard MD; Johnson CL
    Cell Death Differ; 2001 Sep; 8(9):899-908. PubMed ID: 11526445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with Cisplatin induced apoptosis.
    Kamal A; Datta K
    Apoptosis; 2006 May; 11(5):861-74. PubMed ID: 16544101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of protein kinase C delta downregulation by protein kinase C epsilon and mammalian target of rapamycin complex 2.
    Basu A; Sridharan S; Persaud S
    Cell Signal; 2009 Nov; 21(11):1680-5. PubMed ID: 19632318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells.
    Rusnak JM; Lazo JS
    Exp Cell Res; 1996 Apr; 224(1):189-99. PubMed ID: 8612685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.
    Kamarajan P; Sun NK; Chao CC
    Biochem J; 2003 Nov; 376(Pt 1):253-60. PubMed ID: 12911332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
    Basu A; Lazo JS
    Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C.
    Basu A; Akkaraju GR
    Biochemistry; 1999 Apr; 38(14):4245-51. PubMed ID: 10194341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.